Big biotech, Partnering, Pharma

Topotarget and Spectrum amends pharma licensing deal for Belinostat

Posted on 08 October 2013

Tags: , ,

Topotarget and Spectrum Pharmaceuticals, a big biotech comapny, announce an amendment to the companies’ existing pharma licensing agreement.

Pursuant to the pharma licensing amendment, Spectrum Pharmaceuticals will carry the responsibility for the commercial manufacture of belinostat for a 5-year period with the possibility of renewal.

In collaboration, Topotarget and Spectrum Pharmaceuticals have made an amendment to the License Agreement dated February 2, 2010.

The amendment entails a shift from Topotarget to Spectrum in the area of world-wide clinical, commercial, and Named Patient product supply.

Henceforward, Spectrum carries the responsibility for the future manufacture of belinostat for all territories.

The pharma licensing agreement has a term of 5 years with possibility for prolongation; alternatively Topotarget may, at its own choice, take over the responsibility of manufacturing belinostat in Topotarget’s commercial territory.

For further deal information visit Current Agreements (subscription required)


Read: more on partnering deals in pharma, biotech, life science partnering deal news, insights and glossary

Report: Partnering Deals and Alliances with Big Biotech

View: Top 50 biotech – overview of top 50 biotechnology companies by revenue – partnering activity, deal news, partnering dealtalk

Browse: Complete Current Partnering report catalog

View: Current Partnering’s Partnering Scorecard – view top life science partnering deals by value

View: Current Partnering’s Deal Metrics – the latest deal trend infographics for life science deal making

View: Current Partnering’s Big Pharma Deal Making Scorecard – latest trends in big pharma deal making activity

View: Current Partnering’s Big Biotech Deal Making Scorecard – latest trends in big biotech deal making activity

Signup: Current Partnering Dealmakers Update – weekly newsletter providing the latest life science industry deal news, deal making trends, partnering events – sign up now

Signup: Current Agreements Deals Review – monthly newsletter - reviewing the previous month’s life science deal making – partnering, M&A and financing – sign up now

Subscribe: Current Agreements life sciences partnering, M&A and financing deals database – find out more

Follow us on: LinkedIn Current Partnering | LinkedIn Business Development Network | @Currentpartner on Twitter

Print Friendly, PDF & Email

Leave a Reply